Recherche en direct
TopFind récupère les correspondances les plus récentes pour votre recherche.
Nous avons examiné 10000 résultats en direct pour cosentyx direct to patient platform et retenu les 3 options qui semblent les plus utiles à comparer en premier.
Les thèmes les plus forts dans cette sélection sont Patient Support et Pharmaceutical Access.
Source: Novartis Pharmaceuticals Corporation
Description
A manufacturer-backed access program in the US that allows cash-paying patients to bypass traditional insurance hurdles to obtain secukinumab directly. This ensures continuous access for those without standard coverage.
Idéal pour
Cash Paying patients, Uninsured individuals, US residents et Manufacturer direct access
Évaluation
Source: ASPN Pharmacies
Description
Specialized fulfillment and pharmacy services for secukinumab orders originating from the manufacturer's direct-access platform. They handle the cold-chain logistics and delivery of biologic pens and syringes to US patient addresses.
Idéal pour
Direct To Patient delivery, Specialized pharmacy fulfillment, US biologic patients et Cold Chain pharmacy service
Évaluation
Source: Novartis Malaysia
Description
Cosentyx (Secukinumab) is an interleukin inhibitor prescribed for plaque psoriasis and psoriatic arthritis. It is supplied as a 150 mg/mL solution for injection in a pre-filled pen or syringe.
Idéal pour
Plaque psoriasis, Psoriatic arthritis et Interleukin inhibition
Évaluation
| Comparer | Cosentyx Direct-to-Patient Platform | Cosentyx Direct Fulfillment Service | Cosentyx |
|---|---|---|---|
| Source | Novartis Pharmaceuticals Corporation | ASPN Pharmacies | Novartis Malaysia |
| Description | A manufacturer-backed access program in the US that allows cash-paying patients to bypass traditional insurance hurdles to obtain secukinumab directly. This ensures continuous access for those without standard coverage. | Specialized fulfillment and pharmacy services for secukinumab orders originating from the manufacturer's direct-access platform. They handle the cold-chain logistics and delivery of biologic pens and syringes to US patient addresses. | Cosentyx (Secukinumab) is an interleukin inhibitor prescribed for plaque psoriasis and psoriatic arthritis. It is supplied as a 150 mg/mL solution for injection in a pre-filled pen or syringe. |
| Idéal pour | Cash Paying patients, Uninsured individuals, US residents et Manufacturer direct access | Direct To Patient delivery, Specialized pharmacy fulfillment, US biologic patients et Cold Chain pharmacy service | Plaque psoriasis, Psoriatic arthritis et Interleukin inhibition |
| Action | |||
| Évaluation |
Si vous voulez commencer par l'option la plus équilibrée, je vous recommande :
"Cosentyx Direct-to-Patient Platform de Novartis Pharmaceuticals Corporation."
Je l'ai choisi parce que The most effective path for US-based patients without insurance to access manufacturer-direct pricing and support.